Novavax Inc 10-K for FY2025
Novavax Inc (NVAX)
10-K
2026-02-26
For: 2025-12-31
View Original
Added on
April 12, 2026
About this 10-K
Novavax Inc filed this 10-K on February 26, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.12B
- up 64.7% from $682.16M a year earlier
- Net income
- $440.3M
- compared with a net loss of $187.5M a year earlier
- Diluted EPS
- $2.58
- compared with -$1.23 a year earlier